Omada Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-12.8M | $-47.1M | $-67.5M |
| Depreciation & Amortization | $5.5M | $4.8M | $4.4M |
| Depreciation | $700.0K | $600.0K | $700.0K |
| Amortization | $1.9M | $2.0M | $2.0M |
| Stock-Based Compensation | $13.0M | $9.4M | $8.7M |
| Net Cash from Operating Activities | $18.3M | $-34.2M | $-49.7M |
| Investing Activities | |||
| Capital Expenditures | $1.3M | $596.0K | $416.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-5.8M | $-3.9M | $-2.9M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $133.2M | $-1.2M | $179.0K |
| Net Change in Cash | $145.6M | $-39.3M | $-52.5M |
| Free Cash Flow | $16.9M | $-34.8M | $-50.2M |